Regional Anesthesia by PENG-Block in Emergency Department (NCT05673486) | Clinical Trial Compass
CompletedNot Applicable
Regional Anesthesia by PENG-Block in Emergency Department
France36 participantsStarted 2023-03-31
Plain-language summary
The study is a single-centre, open-label randomized comparative trial. Adult patients admitted to the emergency department for a hip fracture will be enrolled.
Pericapsular nerve block (PENG-block) is a regional anesthesia technique developed primarily as an analgesic technique in a perioperative setting during hip fractures related surgical procedures. Some authors propose the use of PENG-Block as an alternative to fascia iliaca block and femoral block for the analgesic management of hip fracture in the emergency department, but scientific evidence is weak in this setting.
The hypothesis of this study is that the use of PENG Block in the emergency department provides a better pain management for patients suffering from hip fractures with less opioid use.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Adult patients (≥18 years old) admitted to the emergency department for a hip fracture
✓. Pain assessed by VAS/NRS ≥ 3 when the clinical suspicion of hip fracture is confirmed by the emergency physician
✓. Patients capable of expressing his/her consent prior to participation in the study
✓. Affiliated to or beneficiary of a social security regimen
Exclusion criteria
✕. Patients for who it is impossible to collect the pain assessment scale
✕. Patients with known or suspected bleeding disorders :
✕. Patients in whom it is impossible to perform the PENG-Block: Body Mass Index (BMI) \> 40, adenopathy or infection at the puncture site, allergy to the anesthetics used
✕. Pregnant, parturient or breastfeeding women
✕. Patients under judicial protection or judicial safeguard
What they're measuring
1
Total morphine consumption
Timeframe: Up to 24 hours after randomization
Trial details
NCT IDNCT05673486
SponsorCentre Hospitalier Intercommunal de Toulon La Seyne sur Mer